[NJ-Diabetes-Division] FW: from less read it is good info Fw: Blind Vine with a share from our reader, Alfred Fredel about new glucose monitoring

Sun Dec 9 16:03:01 UTC 2018

From: Lester Cameron <underdogmj at comcast.net> 
Sent: Friday, November 9, 2018 2:14 PM
To: ange.mperone at optimum.net <angela.mperone at optimum.net>
Subject: from less read it is good info Fw: Blind Vine with a share from our reader, Alfred Fredel about new glucose monitoring

ange do not answer this email to me 

and any email you may sent to me will be automatically will return to you  

this is some thing  u should look in to because you do not watch your sugar close enough that is y u have so manny hi’s and low’s  

From: Debbie Azzarone <mailto:dea23 at optonline.net>  

Sent: Friday, November 09, 2018 1:19 PM

To: Debbie Azzarone <mailto:dea23 at optonline.net>  

Subject: Blind Vine with a share from our reader, Alfred Fredel about new glucose monitoring

Hello Viners,

Here’s a share from Alfred Fredel that will interest diabetics.

This app, unlike others, I’m happy to see has text to speech capabilities.

Endocrinology

o    Diabetes <https://www.healio.com/endocrinology/diabetes> 

FDA approves mobile app for Freestyle Libre

November 1, 2018

The FDA approved a mobile app for use with the Freestyle Libre 10-day and 14-day glucose monitoring systems, allowing patients with diabetes to monitor glucose readings on their compatible iPhone devices, Abbott announced in a press release.

The FreeStyle LibreLink app enables users to hold their iPhone near their FreeStyle Libre or FreeStyle Libre 14-day sensor to instantly capture and view their real-time glucose levels, assess their 8-hour glucose history, and see a directional arrow indicating how their glucose is changing, according to the release. The FreeStyle LibreLink app also includes a series of in-app reports that visualize trends and patterns to help patients understand how well they are controlling their glucose.

See Also

*          <https://www.healio.com/endocrinology/diabetes/news/online/%7B3c13c116-ba4c-4296-a476-8d1abf796cd3%7D/fda-approves-14-day-freestyle-libre-cgm-sensor-for-diabetes> FDA approves 14-day FreeStyle Libre CGM sensor for…

“We’re committed to liberating people from the many hassles of diabetes management through our life-changing technology and tools,” Jared Watkin, senior vice president of Diabetes Care at Abbott, said in the release. “The FreeStyle LibreLink app is a digital health tool that integrates glucose data directly on a compatible smartphone so all of the mobile apps that people use every day are in one convenient place. This is another step forward in making glucose monitoring seamlessly fit into a patient’s daily lifestyle — helping them live a fuller, healthier life.”

According to the press release, The FreeStyle LibreLink app has several new features as compared with the FreeStyle Libre and FreeStyle Libre 14-day readers, including a larger, high-resolution display, text-to-speech capabilities for glucose readings (when enabled), the ability to log smaller doses of insulin (0.1 U vs. 0.5 U), and support for 26 languages.

FreeStyle LibreLink users also have the option to automatically share their glucose information with their health care professional and caregivers.

FreeStyle LibreLink app will be free to download through the Apple App Store in the coming weeks, according to Abbott. Once available, patients will be able to pair the  <https://www.freestylelibre.us/?source=freestylelibre.com> FreeStyle Libre or FreeStyle Libre 14-day sensors with the app. The Android version of the app is currently under development.

As  <https://www.healio.com/endocrinology/diabetes/news/online/%7b3c13c116-ba4c-4296-a476-8d1abf796cd3%7d/fda-approves-14-day-freestyle-libre-cgm-sensor-for-diabetes> Endocrine Today previously reported, the FDA in July approved the FreeStyle Libre flash glucose monitoring system, which allows patients with diabetes to wear the sensor up to 14 days with high accuracy. That approval made Abbott’s continuous glucose monitor the longest-lasting, self-applied personal glucose sensor available on the market, with improved accuracy and reduced warmup time. The FDA approved a 10-day version of the CGM system in  <https://www.healio.com/endocrinology/diabetes/news/online/%7b3c13c116-ba4c-4296-a476-8d1abf796cd3%7d/fda-approves-14-day-freestyle-libre-cgm-sensor-for-diabetes> September 2017, making it the first CGM system in the U.S. that did not require finger-stick calibration for adults with diabetes. 

The FreeStyle LibreLink app is compatible with near-field communication (NFC)-enabled phones on Apple’s iPhone 7 and later, running iOS 11 and later. – by Regina Schaffer

Thanks Alfred

Your Blind Vine Team

"A friend is someone who knows the song in your heart and can sing it back to you when you have forgotten the words." -Unknown

-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://nfbnet.org/pipermail/nj-diabetes-division_nfbnet.org/attachments/20181209/c24d7865/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: image001.png
Type: image/png
Size: 168 bytes
Desc: not available
URL: <http://nfbnet.org/pipermail/nj-diabetes-division_nfbnet.org/attachments/20181209/c24d7865/attachment.png>